Download PDF
Pharmacopsychiatry 2005; 38(4): 161-165
DOI: 10.1055/s-2005-871238
Original Paper
© Georg Thieme Verlag Stuttgart · New York

Psychotropic Drug Presentation in Medical and Lay Press Journals

C. Correll1 , M. Linden1
  • 1Research Group Psychosomatic Rehabilitation Charité, University Hospital Benjamin Franklin, Hindenburgdamm 30, 12209 Berlin, Germany
Further Information

Publication History

Received: 9.2.2004 Revised: 17.3.2004

Accepted: 26.1.2005

Publication Date:
18 July 2005 (online)

Also available at
    Permissions and Reprints

Objective: Media coverage of psychotropic medications affects public views and patients’ and therapists’ compliance. This study is aimed to identify characteristics of and differences between medical and lay press presentations of psychotropic drugs. Methods: Two leading German medical and three lay press journals were analyzed in seven annual sets, ranging from 1963 to 1996. Results: There is a clear difference in the reporting on psychotropic drugs between the different types of journals. Lay press journals primarily focuss on minor tranquilizers and hypnotics which are indiscriminately presented as one group with other psychotropics, have a rather critical view on these drugs and underrepresent the needs for treatment of major mental illnesses. There were no marked trends over time in the attitude towards psychotropics. On comparing the publications before and after 1984, when benzodiazepines were put under schedule IV by WHO, differences in reports on dependency problems can only be found for the daily newspaper. Conclusion: It is the responsibility of psychiatrists to enter the public discussion on how psychiatric disorders should be treated and to run public ”awareness programmes”.

References

  • 1 Angermeyer M C, Matschinger H. Laientheorien über schizophrene Störungen und deren Behandlung.  Fortschr Neurol Psychiatr. 1992;  60 (Sonderheft 2) 105-106
    PubMedGoogle Scholar
  • 2 Angermeyer M C, Däumer R, Matschinger H. Benefits and risks of psychotropic medications in the eyes of the general public: results of a survey in the Federal Republic of Germany.  Pharmacopsychiatry. 1993;  26 114-120
    PubMedGoogle Scholar
  • 3 Angermeyer M C, Matschinger H. Public attitude towards psychiatric treatment.  Acta Psychiatr Scand. 1996;  94 326-336
    PubMedGoogle Scholar
  • 4 Angermeyer M C, Matschinger H. Public attitudes towards psychotropic drugs: Have there been any changes in recent years?.  Pharmacopsychiatry. 2004;  37 152-156
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Benkert O, Graf-Morgenstern M, Hillert A, Sandmann J, Ehmig S C, Weissbecker H, Kepplinger H M, Sobota K. Public opinion on psychotropic drugs: an analysis of the factors influencing acceptance or rejection.  J Nerv Ment Dis. 1997;  185 151-158
    CrossrefPubMedGoogle Scholar
  • 6 Benkert O, Kepplinger H M, Sobota K. Psychopharmaka im Widerstreit: Eine Studie zur Akzeptanz von Psychopharmaka - Bevölkerungsumfrage und Medienanalyse. Berlin; Springer-Verlag 1995
    Google Scholar
  • 7 Brown S D, Landry F J. Recognizing, reporting, and reducing adverse drug reactions.  South Med J. 2001;  94 370-373
    PubMedGoogle Scholar
  • 8 Bury M, Gabe J. Hooked? Media responses to tranquillizer dependence. In: Abbot P, Payne G, editors New Directions in the Sociology of Health London. Palmer Press 1990a
    Google Scholar
  • 9 Bury M, Gabe J. A sociological view of tranquillizer dependence: challenges and responses. In: Hindmarch I, Beaumont G, Brandon S, Leonard BE, editors Benzodiazepines: Current Concepts (Biological, Clinical and Social Perspectives). New York; John Wiley and Sons 1990b
    Google Scholar
  • 10 Cassels A, Hughes M A, Cole C, Mintzes B, Lexchin J, McCormack J P. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.  CMAJ. 2003;  168 1133-1137
    PubMedGoogle Scholar
  • 11 Cohen L, Morgan P P. Medical dramas and the press: who benefits from coverage?.  CMAJ. 1988;  139 657-661
    PubMedGoogle Scholar
  • 12 Cooperstock R, Lennard H L. Some social meanings of tranquillizer use.  Sociology of Health and Illness. 1979;  1 331-347
    CrossrefPubMedGoogle Scholar
  • 13 Dewan M J, Levy B F, Donnelly M P. A positive view of psychiatrists and psychiatry.  Compr Psychiatry. 1988;  29 523-531
    CrossrefPubMedGoogle Scholar
  • 14 Franz M, Dilo K. Schepank H. Warum „nein“ zur Psychotherapie? Kognitive Stereotypen psychogen erkrankter Patienten aus einer Bevölkerungsstichprobe im Zusammenhang mit der Ablehnung eines Psychotherapieangebotes.  Psychother Psychosom Med Psychol. 1993;  43 278-285
    PubMedGoogle Scholar
  • 15 Gabe J, Bury M. Tranquillisers as a social problem.  Sociol Rev. 1988;  36 320-352
    PubMedGoogle Scholar
  • 16 Gabe J, Gustafsson U, Bury M. Mediating illness: newspaper coverage of tranquilliser dependence.  Sociol Health Illness. 1991;  13 332-353
    PubMedGoogle Scholar
  • 17 Gaebel W. Qualitätssicherung in der Psychiatrie.  Nervenarzt. 1995;  66 481-493
    PubMedGoogle Scholar
  • 18 Gaebel W. Psychiatrie und Öffentlichkeit.  Nervenarzt. 1996;  67 336-337
    PubMedGoogle Scholar
  • 19 Gaedt F, Gaedt C, Reuband K H. Zur Rauschmittelberichterstattung der Tageszeitungen in der Bundesrepublik Deutschland und West-Berlin. Ergebnisse einer Inhaltsanalyse. In: Reuband KH, editor Rauschmittelkonsum: soziale Abweichung und institutionelle Reaktion. Wiesbaden; Akademische Verlagsgesellschaft 1976: pp. 77-107
    Google Scholar
  • 20 Gerbner G. Toward cultural indicators: The analysis of mass mediated public message systems. In: Gerbner G, Holst OR, Krippendorf K, Paisley WJ, Stone PJ, editors The analysis of communication content. New York; John Wiley and Sons 1969: p. 126
    Google Scholar
  • 21 Helman C G. ‘Tonic’, ‘fuel’, and ‘food’: social and symbolic aspects of the long-term use of psychotropic drugs. In: Gabe J, Williams P, editors Tranquillisers: Social, Psychological and Clinical Perspectives. London; Travistock Publications 1986: pp. 199-225
    Google Scholar
  • 22 Hillert A, Sandmann J, Benkert O. Is there a general rejection of psychotropic drugs? Knowledge and attitudes of the lay public.  Pharmacopsychiatry. 1993;  26 162
    PubMedGoogle Scholar
  • 23 Hillert A, Sandmann J, Ehmig S C, Sobota K, Weisbecker W, Kepplinger H M, Benkert O. Psychopharmacological drugs as represented in the press: results of systematic analysis of newspapers and popular magazines.  Pharmacopsychiatry. 1996;  29 67-71
    PubMedGoogle Scholar
  • 24 Hoffmann-Richter U, Forrer F, Finzen A. Die Schizophrenie in der Frankfurter Allgemeinen Zeitung - ein Lehrstück.  Psychiatr Prax. 2003;  30 4-7
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Hornung W P. Kooperative Pharmakotherapie.  Dt Ärztebl. 1996;  93 A-1465 - 1468
    PubMedGoogle Scholar
  • 26 Ioannou C. Media coverage versus Fluoxetine as the the cause of suicidal ideation.  Am J Psychiatry. 1992;  149 572
    PubMedGoogle Scholar
  • 27 Katschnig H, Etzersdorfer M M. Vorstellungen in der österreichischen Bevölkerung über Natur, Verlauf und Behandelbarkeit psychischer Erkrankungen.  Fortschr Neurol Psychiatr. 1992;  60 (Sonderheft 2) 168
    PubMedGoogle Scholar
  • 28 Kok G, van den Borne B, Mullen P D. Effectiveness of health education and health promotion: meta analyses of effect studies and determinants of effectiveness.  Patient Educat Counsel. 1997;  30 19-27
    CrossrefPubMedGoogle Scholar
  • 29 Kroll A, Dietrich S, Angermeyer C. Die Darstellung der Depression in deutschen Tageszeitungen. Eine Trendanalyse.  Psychiatr Prax. 2003;  30 367-371
    PubMedGoogle Scholar
  • 30 Lamontagne Y, Elie R, Gaydos S, Garceau-Durand Y. Information on mental illness. The use of newspapers, leaflets or both: a comparative study.  Can J Pub Health. 1986;  27 56-57
    PubMedGoogle Scholar
  • 31 Lamontagne Y. The public image of psychiatrists.  Can J Psychiatry. 1990;  35 693-695
    PubMedGoogle Scholar
  • 32 Leimkühler A M, Müller U. Patientenzufriedenheit - Artefakt oder soziale Tatsache?.  Nervenarzt. 1996;  67 765-773
    CrossrefPubMedGoogle Scholar
  • 33 Linden M. Report on the study on the impact of scheduling benzodiazepines in the Federal Republic of Germany. Report for the World Health Organization. Geneva 1990
    Google Scholar
  • 34 Linden M, Kiermeir J. Medizinische Diagnostik und Therapie als kooperativer Problemlöseprozess von Arzt und Patient. Von der „evidenzbasierten“ zur „rationalen evidenzbasierten“ Medizin.  Die Psychiatrie. 2004;  1 42-49
    PubMedGoogle Scholar
  • 35 Manheimer D I, Davidson S T, Balter M B, Mellinger G D, Cisin I H, Parry H J. Popular attitudes and beliefs about tranquillizers.  Am J Psychiatry. 1973;  130 1246-1253
    PubMedGoogle Scholar
  • 36 Morgan J P. Cultural and medical attitudes toward benzodiazepines: conflicting metaphors.  J Psychoactive Drugs. 1983;  15 115-120
    PubMedGoogle Scholar
  • 37 Scheibler F, Pfaff H. Shared decision making. Der Patient als Partner im medizinischen Entscheidungsprozess. Weinheim; Juventa 2003
    Google Scholar
  • 38 Shader R I, Greenblatt D J, Balter M B. Appropriate use and regulatory control of benzodiazepines.  J Clin Pharmacol. 1991;  3 781-784
    PubMedGoogle Scholar
  • 39 Thompson J B. Mass communication and modern culture: contribution to a critical theory of ideology.  Sociology. 1988;  22 359-383
    CrossrefPubMedGoogle Scholar
  • 40 Toutoungi N. Impact of media on drug consumption.  Agressologie. 1989;  30 545-546
    PubMedGoogle Scholar
  • 41 Tyrer P. Medicine and the media.  BMJ. 1984;  288 1531
    PubMedGoogle Scholar
  • 42 Vartanian M E, Morozov P V, Khan I. Conclusions and recommendations. In: Vartanian ME, Morozov PV, Khan I, editors Rational Use of Psychotropic Drugs with Special Emphasis on Non-Psychiatric Settings. Amsterdam; Exerpta Medica 1987: p. vii
    Google Scholar
  • 43 Waldron I. Increased prescribing of Valium, Librium and other drugs - an example of the influence of economic and social factors on the practice of medicine.  Int J Health Serv. 1977;  7 37-62
    PubMedGoogle Scholar
  • 44 Winckelmann H J. Selbstmedikation und der therapiebestimmende Patient. In: Heinrich K, Linden M, Müller-Oerlinghausen B, editors Werden zu viele Psychopharmaka verbraucht?. Stuttgart; Georg Thieme Verlag 1989: pp. 141-152
    Google Scholar
  • 45 Winick C. Reporting drug truth in the media. In: Morgan JP, Kagan DV, editors Society and Medication: Conflicting Signals for Prescribers and Patients Lexington. Massachusetts; Lexington Books 1983
    Google Scholar
  • 46 Woods J H. Abuse liability and the regulatory control of therapeutic drugs: untested assumptions.  Drug Alcohol Depend. 1990;  25 229-233
    PubMedGoogle Scholar

Prof. Dr. Michael Linden

Research Group Psychosomatic Rehabilitation Charité

University Hospital Benjamin Franklin

Hs IV, Rm. 524

Hindenburgdamm 30

12209 Berlin

Germany

Phone: +49 30 8445 4778, +49 3328 345678

Fax: +49 30 8445 4778, +49 3328 345555

Email: linden@zedat.fu-berlin.de

      >